First Surgical Procedure for Sleep Apnea at Nancy University Hospital
A groundbreaking surgical procedure was successfully performed on September 24, 2024, at the Nancy University Hospital in Meurthe-et-Moselle. Led by Doctor Duc Trung Nguyen, this operation marks a significant milestone as it is the first time in France a neurostimulator has been implanted in a patient to treat obstructive sleep apnea-hypopnea syndrome (OSAHS).
The second procedure occurred on October 3, 2024, further solidifying the hospital’s commitment to pioneering innovative treatments for this common yet serious condition.
What is Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)?
OSAHS affects approximately 4% of the population and is characterized by repeated breathing interruptions during sleep. These interruptions—at least five per night, lasting between ten to thirty seconds—can severely impact oxygen supply to the brain, causing micro-arousals and disrupting sleep continuity.
The consequences of such disrupted sleep can range from daily drowsiness and memory issues to severe health risks like cardiovascular disease and stroke. Doctor Duc Trung Nguyen states, “The impacts on health are worrying, exposing patients to risks of hypertension, heart attack, and even diabetes.”
The Neurostimulator Procedure
The surgical procedure involves implanting a neurostimulator in the Hypoglossal nerve, which controls tongue movement during sleep. A probe is positioned in the rib cage, similar to a pacemaker, to detect respiratory activity. If breathing stops, the device sends a signal that triggers the tongue to move forward, clearing the airway and resuming normal breathing.
This technique offers an alternative for patients who cannot tolerate conventional treatments such as continuous positive airway pressure (CPAP) or mandibular advancement orthosis. According to Doctor Duc Trung Nguyen, “Studies show that 40% of patients abandon CPAP treatment within four years due to its restrictive nature.”
Procedure Details
The implantation is performed under general anesthesia and requires periodic battery replacements every ten years. The hospital collaborates closely with a sleep medicine and research center, as well as the pulmonology department, to ensure comprehensive care for patients.
Health Insurance and Accessibility
The decision to reimburse the neurostimulator procedure by Health Insurance, effective since August 2024, allows this innovative treatment to become more accessible to patients throughout France. With Nancy University Hospital leading the way, many patients will now have the opportunity to receive this life-changing therapy.
Understanding the Impact of OSAHS
Beyond the immediate symptoms, OSAHS can have long-term repercussions on a person’s health and quality of life. Here are some key points to consider:
- Drowsiness and Fatigue: Patients often experience excessive sleepiness, impacting work performance and daily activities.
- Cognitive Issues: Memory and concentration impairments can stem from fragmented sleep patterns.
- Cardiovascular Risks: Increased likelihood of hypertension, heart disease, and stroke.
- Accident Proneness: Drowsiness can lead to higher risks of accidents at work or while driving.
Patient Testimonials and Case Studies
While the procedures at the Nancy University Hospital continue to unfold, preliminary success stories are already emerging from patients who underwent the neurostimulator implantation. Future sections will detail their experiences, highlighting improvements in sleep quality and overall well-being.
Conclusion
With the successful implementation of the neurostimulator for obstructive sleep apnea at the Nancy University Hospital, a new chapter in sleep medicine has begun in France. This innovative approach not only offers patients relief from a debilitating condition but also sets the stage for further advancements in surgical treatments for sleep disorders.
